Here are four things to know:
1. The companies’ distribution partnership began in 2010 and has now holds significant spine market position in Australia and New Zealand.
2. The new five-year agreement aims to promote added success to the companies’ spine market position in Australia and New Zealand.
3. LifeHealthcare CEO Matt Muscio said, “Through our partnership, we have delivered highly successful product initiatives, such as the EVEREST MI XT and MESA platforms, and market leading education forums, such as Deformity Down Under, to address the needs of Australian and New Zealand clinicians and their patients.”
4. K2M President and CEO Eric Major said, “LifeHealthcare has been an important strategic partner of ours for many years and their established distribution presence and strong surgeon relationships have been instrumental in K2M’s strong market share growth in Australia and New Zealand.”
More articles on devices:
Global interventional spine devices market to grow at 10.5% CAGR through 2021 — 5 observations
Alphatec launches device for MIS lateral access procedures — 5 takeaways
Zimmer Biomet recalls Comprehensive Reverse Shoulder device — here’s why
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
